Abamectin (avermectin) is a natural fermentation product of Streptomyces avermitilis and is widely used as a pesticide. Recently, it has been used as an antiparasitic agent. This study aims at assessing the impact of abamectin on hamsters infected with Schistosoma mansoni. Parasitological, histopathological parameters, glycolytic enzymes, liver function enzymes and cytokines were assessed in an infected hamster model. The data indicated that a significant decrease in the number of worms in Abamectin treated group as well as in the number of mature and live ova in the treated group. Also, treatment of the infected hamster with Abamectin recorded no significant difference in all glycolytic enzymes (PK, GPI and HK). Furthermore, Abamectin recorded no significant difference in the level of LDH, AST and ALT (liver function enzymes) as compared to S. mansoni infected group. In addition, immunization caused a slight decline in granuloma diameter, an increase in the immunoglobulins and cytokines. Also, histopathological results showed that Abamectin caused multinucleated histolytic inflammatory giant cell with cytoplasmic engulfed foreign bilharzial pigment in the liver tissue without viable bilharzial egg. In conclusion, the present data indicated that significant decline of parasitological parameters and no side effects of most parameters compared to the normal healthy control group.
Published in | International Journal of Chinese Medicine (Volume 1, Issue 3) |
DOI | 10.11648/j.ijcm.20170103.14 |
Page(s) | 92-101 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2017. Published by Science Publishing Group |
Abamectin, Schistosoma mansoni, Product of Streptomyces avermitilis, Liver Function Enzymes, Glycolytic Enzymes
[1] | King CH, Dickman K, Tisch DJ. (2005). Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability- related outcomes in endemic schistosomiasi. Lancet 365: 1561-1569. |
[2] | Gryseels B, Polman K, Clerinx J, Kestens L. .(2006). Human schistosomiasi. Lancet, 368: 1106-18. |
[3] | Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J..(2006) Schistosomiasis and water resources development: Systematic review, meta-analysis and estimates of people at risk. Lancet infec Dis, 6: 411-25. |
[4] | Sayed AA, Simeonov A, Thomas CJ, Inglese J, Austin CP, Williams DL. (2008). Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat Med., 4: 407-412. |
[5] | Greenberg RM. (2005). Are Ca2+ channels target of praziquantel action? Int J Parasitol, , 35: 1-9. |
[6] | Utzinger J, Keiser J. (2004) Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother 5, 263-285. |
[7] | World Health Organization(2006). Preventive chemotherapy in human helminthiasis. World Health Organization, Geneva, Switzerland. |
[8] | World Health Organization Schistosomiasis (2011). number of people treated in 2009. Wkly. Epidemiol. Rec. 86: 73-80. |
[9] | Xiao SH, Mei JY, Jiao PY.(2011). Effect of mefloquine administrated orally at single, multiple or combined with artmether, artesunate or praziquantel in treatment of mice infected with Schistosomajaponicum. Parasitol Res, 108: 399-406. |
[10] | Caffrey CR.(2007). Chemotherapy of schistosomiasis: present and fyture. Curr Opin Chem Biol 11: 433-99. influences of IL-1, IL-18 and HMGB1, Cytokine. 69(1): 136–145. |
[11] | Nassauw LV, Toovey S, Van Op den bosch J, Timmermans J, Vercruysse J. (2008). Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni- infected mice. Trav Med Infec Dis, 6: 253-258. |
[12] | Keiser J, Chollet J, Xiao S, Mei J, Jiao P, Utzinger J, Tanner M.(2009). Mefloquine – an aminoalcohol with promising antischistosomal properties in mice. PLOS Negl Trop Dis, 3: e350. |
[13] | Harvie, M., Jordan, T. W., Flamme, A. C. L.(2007). Differential liver protein expression during Schistosomiasis. Infec. Immun., 75, 736-744. |
[14] | Friedman SL.(2003). Liver fibrosis –from bench to bedside. J. Hepatol. 38 (238): 538-53. |
[15] | Trinder. P.(1969). Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem., 6: 24-27. |
[16] | Romeih MH, Hassan HM, Shousha TS, Saber MA. (2008). Immunization against Egyptian Schistosomamansoniinfection by multivalent DNA vaccine: Acta. Biochim. Biophys. Sin. (Shanghai). 40: 327-38. |
[17] | Bergquist R, Utzinger J, Mc Manus DP.(2008). Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS. Negl. Trop. Dis. 2: 244-252. |
[18] | Lanks, G. R. and Cordon, L. R. Toxicology. N. I. N. (1989) (Ivermectinand Abamectin), Cempbell, W. C., Ed. Springer-verlag. New York, London, Paris, Tokyo. |
[19] | Benz, G. W. and Cox, J. L. (1989). Use of Abamectin in Cattle, In (Ivermectin and Abamectin), [Cempbeu W. C., Ed. Springer-verlag, New York, London, Paris, Tokyo. |
[20] | Mohamed, A. M., Bakry, F. A. and Heiba, F. N.(2000). Molluscicidal effects of Abamectin on Biomphalaria alexandrina and its inflection with Schistosoma mansoni J. 1st Inter. Cong. Biolg. Sci.,(ICBS) 1 (2) : 207-216. |
[21] | WHO (1965): Molluscicide screening and evaluation. Bull. WHO, 33: 5675 |
[22] | Litchfield, JT. and Wilcoxon, F. (1949). A simplified method of evaluating dose effect experiments. J. Pharmacol. Exp. Therap., 96: 99-113. |
[23] | Xue J, Liu S, Qiang HQ, Ren HN, Li TH, Xue HC, Hotez PJ, Xiao SH, (2003).Necatoramericanus: maintenance through one hundred generations in golden hamsters (Mesocricetus auratus). I. Host sex-associated differences in hookworm burden and fecundity. Exp Parasitol, 104: 62–66. |
[24] | Kloetzel,K.(1967). Egg and pigment production in Schistosomamanson infections of the white mouse. Am. J Trop. Med. Hyg. 12, 293. |
[25] | Pellegrino, J., Oliveira, C. A., Faria,J. and Cunha,A.(1962). New approach to the screening of drugs in experimental Schistosomamanson in mice. Am. J. Trop. Med. Hyg., 11 (1). 301. |
[26] | Cheever AW.(1968). Conditions affecting accuracy of KOH digestion techniques for counting S. mansoni eggs in tissues. Bull. WHO, 39: 329-331. |
[27] | Kamel, I. A., Cheever, A. W., Elwi, A. M., Mosimann, J. E. and Danner, R. (1977). Schistosomamanson and Schistosomahae matobium infections in Egypt. Technique for recovery of worms at necropsy. Am. J. Trop. Med Hyg., 1977. 26, 696. |
[28] | Uyeda, K. & Racker, E.(1965). Regulatory mechanisms in carbohydrate metabolism. VII. Hexokinase and phosphofructokinase. J. Biol. Chem. 240: 4682-4688. |
[29] | McManus, D. P. & James, B. L.(1975). Anaerobic glucose metabolism in the digestive gland of Littorinasaxatilisrudis (Maton) and the daughter sporocysts Microphallussimilis (jag). Comp. Biochem. Physiol. 51 (13): 293-297. |
[30] | Cabaud, P. &Wroblewski, F.(1958). Colorimetric measurement of lactic dehydrogenase activity of body fluids. Am. J. Clin. Pathol. 30, 234. |
[31] | King, Y. S.(1974). Cultivation of Bulinusphysopsisglobsous (Morelt) and Biomphalariapfeifferi (Krauss) snail hosts of schistosomiasis. Sterkiana, (7): 52-54. |
[32] | Reitman, S. and Frankel, SA.(1957). colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Amer. J. Clin. Pathol., 28: 56. |
[33] | Fishman, W. H. and Ferner, FJ. (1953).Biol. Chem. 200: 89-97. |
[34] | Engvall E, Perlman P.( 1971) Enzyme linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. J. Immunochem. 8: 871-874. |
[35] | Von Lichtenberg F. (1962). Host response to eggs of Schisosoma mansoni L. Granuloma formation in he unsenatitized laboratory mouse. American journal of Pahology 41. 711-731. |
[36] | Petrie, A. and Sabin, C.(2000). Medical statistics at a Glance. Blackwell Science Ltd, Oxford. |
[37] | Ritchie, L. S., Lopez, V. A., Cora, J. M. (1974). prolonged applications of an organotin against Biomphalariaalexandrina and Schistosomamansoni in molluscicides in Schistosomiasis control: TC. Change Ed Academic press New York and London: ppts: 77 - 88. |
[38] | Viyanant,V., Thirachantra,S. and Sornmani,S.(1982).The effect of controlled release copper sulfate and tributyltin fluoride on the mortality and infectivity of Schistosomamansonmiracidia. Southeast Asian J. Trop. Med. Pub. Hilth., 13 (2), 225. |
[39] | Gawish, F. M.(1997). Evaluation of combination of certain molluscicide against Biomphalariaalexandrina and the free living stages of Schistosomamansoni. Ph. D. Thesis, Zoology Dep. Girls Coll. For Arts, Sci. & Education, Ain 32 |
[40] | WHO.(1963). Data sheet on pesticides. No. 63,Niclosamide. WHONBC/DC/88. 63. |
[41] | Rollino C, Guzman H,Beltrame G, Ferro M, Quattrocchio G, Bellis D, Quarello F.(2008). Retroperitoneal fibrosis and schistosomiasis: A causal relationship? Europ. J. Inter. Med., 19: 297 - 299. |
[42] | Spicher VM, Genin B, Jordan AR, Brandt LR, Coultre CL.(2004). Peritoneal schistosomiasis: An unusual Laparoscopic Finding. J. pediat. Surg., 39: 631-633. |
[43] | Tielens, A. G.(1997). Biochemistry of Trematode. In: Advances in Trematode Biology (Fried, B and Graczyk, T. K. Ed). pp 309-343. |
[44] | Metwally, A. A; Janku, I; Komper, F.; Khayyal, M. T; Fbeid, F. A. and Botros, S. S.(1990). Effect of schistosomiasis infection on the clearance of phenazone in mice. Arzneim forsch. 1990, 40, 206. |
[45] | Kuser, P. R; Krauchrenco, S; Antunes, O. A. and Polikarpov, I.(2000).The high resolution crystal structure of yeast Hexokinase with the correct primary sequence provides new insights into its mechanism of action. J. Biol. Chem. 275, 20814. |
[46] | ElAasar, A. A; ElMerzabani, M. M; Zakhary, N. I; Farag, H. I; Abdeen, A. M; Abd El-Salam, I. and Mokhtar, N. M.(1989).Biochemical and biophysical studies on schistosomal liver of mice. Egypt. J. Bilh. 1989, 11, 19. |
[47] | El-Shazly, A. M; Soliman, M; ElKalla, M. R; Rezk, H; ElNemr, H. E; Handousa, A. E. and Helmy, M. M.(2001).Studies on patients with Schistosomamansoni; HCV and/or typhoid fever. J. Egypt. Soc. Parasitol. 31, 583. |
[48] | Mansour, M. M; Farid, Z; Bassily, S; Salah, L. H. and Watten, R. H.(1982). Serum enzyme tests in hepatosplenic schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 76, 109. |
[49] | Abdel-Rahman, H. M; El-Shanawani, F. M., Hassan, M. M., Salem. M. and El-Salhy, A. M.(1993).Alkaline phosphatase isoenzymes abnormalities in hepatic schistosomiasis Egypt. J. Bilh. 15, 41. |
[50] | Botros S, Doughty B, Shaker Z, Akl M, Sharmy R, Diab T, Hassanein H.(1996). Efficacy of antipathology vaccine in murine schistosomiasis administered with and without chemotherapy. Int. J. Immunopharmacol. 1996. 12: 707-718. |
[51] | Suleiman MI, Akarim EI, Ibrahi KE, Saad AM, Mohammed AE.(2004). Ahmed Sulaiman SM. Antischistosomal effects of praziquantel, its alkaline hydrolysis and sun decomposed products on experimentally S. mansoni infected albino mice. (A) Efficacy a ssesament based on clinicopathological findings. J. Egypt. Soc. Parasitol. 34: 131- 42. |
[52] | Abdel-Ghaffar O.(2004). Assessment of the efficacy of Ro16-2308 against the Egyptian strain of Schistosomamansoniin mico: Parasitological, hematological and biochemical criteria. Egypt. J. Zool. 42: 173-203. |
[53] | Guirguis FR.(2003). Efficacy of praziquantel and Ro 15 - 5458, a q-acridanonchydrazone derivative, against Schistosomahaematobium. Arzeim, Forsch, Drug Res. 3 (1): 57-61. |
[54] | Abath FG, Morais CN, Montenegro CE, Wynn TA, Montenegro SM.(2006). Immunopathogenic mechanisms in schistosomasis: what can be learnt from human studies? Trends Parasitol. 22: 85-91. |
[55] | Cassiman D, Lib brecht L, Desnet V, Denef C, Roskams T (2002). Hepatic Stelalte cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol. 36: 200-209. |
[56] | Mann J, Mann DA.(2009). Transcriptional regulation of hepatic stellate cells. Advanced drug delivery reviews 2009, 61: 497-512. |
[57] | Soren K, Monard J, Johnsen MV, Lindberg R (2009). Persistent immune responses in late infection and after treatment in experimental Schistosoma bovis infections in goats. Res. Vet. Sci. 86: 472-8. |
[58] | Njenga SM, Ng'ang'a PM, Mwanje MT, Bendera FS.(2014a). Bockarie MJ A school-based cross-sectional survey of adverse events following co-administration of albendazole and praziquantel for preventive chemotherapy against urogenital schistosomiasis and soil-transmitted helminthiasis in Kwale County, Kenya, MJ. PLoS One. 9 (2): e88315. |
[59] | Njenga SM, Mutungi FM, Wamae CN.(2014b) Mwanje MT, Njiru KK, Bockarie Once a year school-based deworming with praziquantel and albendazole combination may not be adequate for control of urogenital schistosomiasis and hookworm infection in Matuga District, Kwale County, Kenya. MJ. Parasit Vectors. 19: 7: 74. |
[60] | Kim JJ, Aggvoo V, Bagarazzi ML, CHattergoon MA, Dang K, Wang B, Boyer J D and Weiner DB.(1997). In vivo Engineering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogn. J. Immunol. 158: 816-826. |
[61] | Cheever, A. W. and Anderson, L. A.(1975). Rate of destruction of Schistosomamansoni eggs in tissues of mice. Am. J. Trop. Med. Hyg. 1975., 20, 62. |
[62] | Stadecker MJ, Ashai H, Finger E, Hernandez HJ, Rutitzky, Sun J.(2004). The immunobiology of Th1 polarizaiton in high-pathology Schistosoniasis. Immunol. Rev. 201: 168-179. |
[63] | Nelson DR, Tu 2, soldevila-Pico C.(2003). long-term interleulin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 38: 859-868. |
[64] | Michael JD, Anthony EB.(1988). Schistosomiasis. School Biol. Sc., Univ. Wales, Bangor, Gwynedd, UK., pps: 2139-2140. |
APA Style
Amira I. El-Kabbany, Rania S. Hamza, Somaya M. Ismail, Khaled I. Ghaled. (2017). Effect of Abamectin on Biochemical, Immunological and Histological Parameters of Hamster Infected with Schistosoma mansoni. International Journal of Chinese Medicine, 1(3), 92-101. https://doi.org/10.11648/j.ijcm.20170103.14
ACS Style
Amira I. El-Kabbany; Rania S. Hamza; Somaya M. Ismail; Khaled I. Ghaled. Effect of Abamectin on Biochemical, Immunological and Histological Parameters of Hamster Infected with Schistosoma mansoni. Int. J. Chin. Med. 2017, 1(3), 92-101. doi: 10.11648/j.ijcm.20170103.14
@article{10.11648/j.ijcm.20170103.14, author = {Amira I. El-Kabbany and Rania S. Hamza and Somaya M. Ismail and Khaled I. Ghaled}, title = {Effect of Abamectin on Biochemical, Immunological and Histological Parameters of Hamster Infected with Schistosoma mansoni}, journal = {International Journal of Chinese Medicine}, volume = {1}, number = {3}, pages = {92-101}, doi = {10.11648/j.ijcm.20170103.14}, url = {https://doi.org/10.11648/j.ijcm.20170103.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcm.20170103.14}, abstract = {Abamectin (avermectin) is a natural fermentation product of Streptomyces avermitilis and is widely used as a pesticide. Recently, it has been used as an antiparasitic agent. This study aims at assessing the impact of abamectin on hamsters infected with Schistosoma mansoni. Parasitological, histopathological parameters, glycolytic enzymes, liver function enzymes and cytokines were assessed in an infected hamster model. The data indicated that a significant decrease in the number of worms in Abamectin treated group as well as in the number of mature and live ova in the treated group. Also, treatment of the infected hamster with Abamectin recorded no significant difference in all glycolytic enzymes (PK, GPI and HK). Furthermore, Abamectin recorded no significant difference in the level of LDH, AST and ALT (liver function enzymes) as compared to S. mansoni infected group. In addition, immunization caused a slight decline in granuloma diameter, an increase in the immunoglobulins and cytokines. Also, histopathological results showed that Abamectin caused multinucleated histolytic inflammatory giant cell with cytoplasmic engulfed foreign bilharzial pigment in the liver tissue without viable bilharzial egg. In conclusion, the present data indicated that significant decline of parasitological parameters and no side effects of most parameters compared to the normal healthy control group.}, year = {2017} }
TY - JOUR T1 - Effect of Abamectin on Biochemical, Immunological and Histological Parameters of Hamster Infected with Schistosoma mansoni AU - Amira I. El-Kabbany AU - Rania S. Hamza AU - Somaya M. Ismail AU - Khaled I. Ghaled Y1 - 2017/06/20 PY - 2017 N1 - https://doi.org/10.11648/j.ijcm.20170103.14 DO - 10.11648/j.ijcm.20170103.14 T2 - International Journal of Chinese Medicine JF - International Journal of Chinese Medicine JO - International Journal of Chinese Medicine SP - 92 EP - 101 PB - Science Publishing Group SN - 2578-9473 UR - https://doi.org/10.11648/j.ijcm.20170103.14 AB - Abamectin (avermectin) is a natural fermentation product of Streptomyces avermitilis and is widely used as a pesticide. Recently, it has been used as an antiparasitic agent. This study aims at assessing the impact of abamectin on hamsters infected with Schistosoma mansoni. Parasitological, histopathological parameters, glycolytic enzymes, liver function enzymes and cytokines were assessed in an infected hamster model. The data indicated that a significant decrease in the number of worms in Abamectin treated group as well as in the number of mature and live ova in the treated group. Also, treatment of the infected hamster with Abamectin recorded no significant difference in all glycolytic enzymes (PK, GPI and HK). Furthermore, Abamectin recorded no significant difference in the level of LDH, AST and ALT (liver function enzymes) as compared to S. mansoni infected group. In addition, immunization caused a slight decline in granuloma diameter, an increase in the immunoglobulins and cytokines. Also, histopathological results showed that Abamectin caused multinucleated histolytic inflammatory giant cell with cytoplasmic engulfed foreign bilharzial pigment in the liver tissue without viable bilharzial egg. In conclusion, the present data indicated that significant decline of parasitological parameters and no side effects of most parameters compared to the normal healthy control group. VL - 1 IS - 3 ER -